Somatostatin Analogs Market 2023 Risk, Upstream, Forecast and CAGR...

agregó una foto Other

2024-03-06 10:53:39 -

Somatostatin Analogs Market 2023 Risk, Upstream, Forecast and CAGR - 2032

According to Custom Market Insights (CMI), the global Somatostatin Analogs Market was estimated at USD5.8 billion in 2021 and is projected to reach approximately USD 10 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.5% between 2022 and 2030. The report studies the Somatostatin Analogsmarket’s drivers and restraints, coupled with the impact they have...

0 Commentarios 0 Acciones 264 Views 0 Vista previa